In mouse tumor Leydig cells, we previously demonstrated the GPER-PPARα partnership through the PI3K/Akt pathway, and the effect of the GPER-PPARγ via the Ras/Raf pathway on the cytoskeleton structure, migration competences and morphology of these cells [29]. The gene discussed is PPARG; the disease is neoplasm.